Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.695 CAD | -1.64% |
|
+1.06% | +9.83% |
Jul. 11 | Knight Therapeutics Announced Normal Course Issuer Bid | MT |
Jul. 11 | Knight Therapeutics Brief: Announcing Normal Course Issuer Bid | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.83% | 429M | |
+34.09% | 10.31B | |
+40.41% | 5.23B | |
-15.24% | 4.62B | |
+11.62% | 3.52B | |
+26.25% | 2.31B | |
-38.78% | 1.78B | |
-44.54% | 1.69B | |
-0.50% | 1.64B | |
+0.21% | 1.59B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Transcript : Knight Therapeutics Inc., Q3 2021 Earnings Call, Nov 11, 2021